Gut Mycobiota in Immunity and Inflammatory Disease

Immunity

Volumn 50, Issue 6, 2019, Pages 1365-1379

  Li, Xin V ^a   Leonardi, Irina ^a   Iliev, Iliyan D ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Weill Cornell Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; CELLULAR IMMUNITY; COMMENSAL; DISEASE COURSE; DISEASE EXACERBATION; FUNGAL COMMUNITY; FUNGUS; FUNGUS IMMUNITY; HOMEOSTASIS; HOST MICROBE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; INNATE IMMUNITY; INTESTINE FLORA; LIVER DISEASE; LUNG DISEASE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASE PREDISPOSITION; GASTROENTERITIS; HOST PATHOGEN INTERACTION; IMMUNITY; IMMUNOLOGY; METABOLISM;

ADAPTIVE IMMUNITY; ANIMALS; DISEASE SUSCEPTIBILITY; GASTROENTERITIS; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; IMMUNITY, INNATE;

EID: 85066860252     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2019.05.023     Document Type: Review

References (158)

1. Albenberg, L.G., Wu, G.D., Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology 146 (2014), 1564–1572.
2. Allaire, J.M., Crowley, S.M., Law, H.T., Chang, S.Y., Ko, H.J., Vallance, B.A., The intestinal epithelium: central coordinator of mucosal immunity. Trends Immunol. 39 (2018), 677–696.
3. Allert, S., Förster, T.M., Svensson, C.M., Richardson, J.P., Pawlik, T., Hebecker, B., Rudolphi, S., Juraschitz, M., Schaller, M., Blagojevic, M., et al. Candida albicans-induced epithelial damage mediates translocation through intestinal barriers. MBio, 9, 2018 e00915-18.
4. Arbuckle, M.R., McClain, M.T., Rubertone, M.V., Scofield, R.H., Dennis, G.J., James, J.A., Harley, J.B., Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349 (2003), 1526–1533.
5. Arrieta, M.C., Stiemsma, L.T., Dimitriu, P.A., Thorson, L., Russell, S., Yurist-Doutsch, S., Kuzeljevic, B., Gold, M.J., Britton, H.M., Lefebvre, D.L., et al., CHILD Study Investigators. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med., 7, 2015, 307ra152.
6. Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331 (2011), 337–341.
7. reg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500 (2013), 232–236.
8. Atarashi, K., Tanoue, T., Ando, M., Kamada, N., Nagano, Y., Narushima, S., Suda, W., Imaoka, A., Setoyama, H., Nagamori, T., et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163 (2015), 367–380.
9. Auchtung, T.A., Fofanova, T.Y., Stewart, C.J., Nash, A.K., Wong, M.C., Gesell, J.R., Auchtung, J.M., Ajami, N.J., Petrosino, J.F., Investigating colonization of the healthy adult gastrointestinal tract by fungi. MSphere, 3, 2018 e00092-18.
10. Bacher, P., Schink, C., Teutschbein, J., Kniemeyer, O., Assenmacher, M., Brakhage, A.A., Scheffold, A., Antigen-reactive T cell enrichment for direct, high-resolution analysis of the human naive and memory Th cell repertoire. J. Immunol. 190 (2013), 3967–3976.
11. Bacher, P., Kniemeyer, O., Schönbrunn, A., Sawitzki, B., Assenmacher, M., Rietschel, E., Steinbach, A., Cornely, O.A., Brakhage, A.A., Thiel, A., Scheffold, A., Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi. Mucosal Immunol. 7 (2014), 916–928.
12. Bacher, P., Heinrich, F., Stervbo, U., Nienen, M., Vahldieck, M., Iwert, C., Vogt, K., Kollet, J., Babel, N., Sawitzki, B., et al. Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans. Cell 167 (2016), 1067–1078.e16.
13. Bacher, P., Hohnstein, T., Beerbaum, E., Röcker, M., Blango, M.G., Kaufmann, S., Röhmel, J., Eschenhagen, P., Grehn, C., Seidel, K., et al. Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans. Cell 176 (2019), 1340–1355.e15.
14. Bain, C.C., Bravo-Blas, A., Scott, C.L., Perdiguero, E.G., Geissmann, F., Henri, S., Malissen, B., Osborne, L.C., Artis, D., Mowat, A.M., Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat. Immunol. 15 (2014), 929–937.
15. Bandara, H.M.H.N., Yau, J.Y.Y., Watt, R.M., Jin, L.J., Samaranayake, L.P., Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation. J. Med. Microbiol. 58 (2009), 1623–1631.
16. + T cell clones primed by pathogens or vaccines. Science 347 (2015), 400–406.
17. Bittinger, K., Charlson, E.S., Loy, E., Shirley, D.J., Haas, A.R., Laughlin, A., Yi, Y., Wu, G.D., Lewis, J.D., Frank, I., et al. Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing. Genome Biol., 15, 2014, 487.
18. Boris, S., Barbés, C., Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect. 2 (2000), 543–546.
19. Brand, S., Hofbauer, K., Dambacher, J., Schnitzler, F., Staudinger, T., Pfennig, S., Seiderer, J., Tillack, C., Konrad, A., Göke, B., et al. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype. Am. J. Gastroenterol. 101 (2006), 99–106.
20. Brown, G.D., Denning, D.W., Gow, N.A., Levitz, S.M., Netea, M.G., White, T.C., Hidden killers: human fungal infections. Sci. Transl. Med., 4, 2012, 165rv13.
21. Bulgasem, B.Y., Lani, M.N., Hassan, Z., Wan Yusoff, W.M., Fnaish, S.G., Antifungal activity of lactic acid bacteria strains isolated from natural honey against pathogenic Candida species. Mycobiology 44 (2016), 302–309.
22. Cai, W., Ran, Y., Li, Y., Wang, B., Zhou, L., Intestinal microbiome and permeability in patients with autoimmune hepatitis. Best Pract. Res. Clin. Gastroenterol. 31 (2017), 669–673.
23. Cebula, A., Seweryn, M., Rempala, G.A., Pabla, S.S., McIndoe, R.A., Denning, T.L., Bry, L., Kraj, P., Kisielow, P., Ignatowicz, L., Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 497 (2013), 258–262.
24. Chang, P.V., Hao, L., Offermanns, S., Medzhitov, R., The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. USA 111 (2014), 2247–2252.
25. Chehoud, C., Albenberg, L.G., Judge, C., Hoffmann, C., Grunberg, S., Bittinger, K., Baldassano, R.N., Lewis, J.D., Bushman, F.D., Wu, G.D., Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflamm. Bowel Dis. 21 (2015), 1948–1956.
26. Cheng, S.C., Quintin, J., Cramer, R.A., Shepardson, K.M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E.J., Martens, J.H., Rao, N.A., Aghajanirefah, A., et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science, 345, 2014, 1250684.
27. Chiaro, T.R., Soto, R., Zac Stephens, W., Kubinak, J.L., Petersen, C., Gogokhia, L., Bell, R., Delgado, J.C., Cox, J., Voth, W., et al. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci. Transl. Med., 9, 2017, eaaf9044.
28. Collar, A.L., Swamydas, M., O'Hayre, M., Sajib, M.S., Hoffman, K.W., Singh, S.P., Mourad, A., Johnson, M.D., Ferre, E.M., Farber, J.M., et al. The homozygous CX3CR1-M280 mutation impairs human monocyte survival. JCI Insight, 3, 2018, 95417.
29. Conti, H.R., Gaffen, S.L., IL-17-mediated immunity to the opportunistic fungal pathogen Candida albicans. J. Immunol. 195 (2015), 780–788.
30. Coombes, J.L., Siddiqui, K.R., Arancibia-Cárcamo, C.V., Hall, J., Sun, C.M., Belkaid, Y., Powrie, F., A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204 (2007), 1757–1764.
31. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
32. De Luca, A., Montagnoli, C., Zelante, T., Bonifazi, P., Bozza, S., Moretti, S., D'Angelo, C., Vacca, C., Boon, L., Bistoni, F., et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J. Immunol. 179 (2007), 5999–6008.
33. De Luca, A., Carvalho, A., Cunha, C., Iannitti, R.G., Pitzurra, L., Giovannini, G., Mencacci, A., Bartolommei, L., Moretti, S., Massi-Benedetti, C., et al. IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis. PLoS Pathog., 9, 2013, e1003486.
34. Doron, I., Leonardi, I., Iliev, I.D., Profound mycobiome differences between segregated mouse colonies do not influence Th17 responses to a newly introduced gut fungal commensal. Fungal Genet. Biol. 127 (2019), 45–49.
35. Eiseman, B., Silen, W., Bascom, G.S., Kauvar, A.J., Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44 (1958), 854–859.
36. El-Azizi, M.A., Starks, S.E., Khardori, N., Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms. J. Appl. Microbiol. 96 (2004), 1067–1073.
37. El-Gabalawy, H., Guenther, L.C., Bernstein, C.N., Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J. Rheumatol. Suppl. 85 (2010), 2–10.
38. Ene, I.V., Farrer, R.A., Hirakawa, M.P., Agwamba, K., Cuomo, C.A., Bennett, R.J., Global analysis of mutations driving microevolution of a heterozygous diploid fungal pathogen. Proc. Natl. Acad. Sci. USA 115 (2018), E8688–E8697.
39. Eyre, D.W., Sheppard, A.E., Madder, H., Moir, I., Moroney, R., Quan, T.P., Griffiths, D., George, S., Butcher, L., Morgan, M., et al. A Candida auris outbreak and its control in an intensive care setting. N. Engl. J. Med. 379 (2018), 1322–1331.
40. Fan, D., Coughlin, L.A., Neubauer, M.M., Kim, J., Kim, M.S., Zhan, X., Simms-Waldrip, T.R., Xie, Y., Hooper, L.V., Koh, A.Y., Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat. Med. 21 (2015), 808–814.
41. Fanucchi, S., Fok, E.T., Dalla, E., Shibayama, Y., Börner, K., Chang, E.Y., Stoychev, S., Imakaev, M., Grimm, D., Wang, K.C., et al. Immune genes are primed for robust transcription by proximal long noncoding RNAs located in nuclear compartments. Nat. Genet. 51 (2019), 138–150.
42. Findley, K., Oh, J., Yang, J., Conlan, S., Deming, C., Meyer, J.A., Schoenfeld, D., Nomicos, E., Park, M., Kong, H.H., Segre, J.A., NIH Intramural Sequencing Center Comparative Sequencing Program. Topographic diversity of fungal and bacterial communities in human skin. Nature 498 (2013), 367–370.
43. Fisher, M.C., Hawkins, N.J., Sanglard, D., Gurr, S.J., Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science 360 (2018), 739–742.
44. Fujimura, K.E., Sitarik, A.R., Havstad, S., Lin, D.L., Levan, S., Fadrosh, D., Panzer, A.R., LaMere, B., Rackaityte, E., Lukacs, N.W., et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat. Med. 22 (2016), 1187–1191.
45. Gilbert, J.A., Blaser, M.J., Caporaso, J.G., Jansson, J.K., Lynch, S.V., Knight, R., Current understanding of the human microbiome. Nat. Med. 24 (2018), 392–400.
46. Gunsalus, K.T., Tornberg-Belanger, S.N., Matthan, N.R., Lichtenstein, A.H., Kumamoto, C.A., Manipulation of host diet to reduce gastrointestinal colonization by the opportunistic pathogen Candida albicans. MSphere, 1, 2015 e00020-15.
47. Hadis, U., Wahl, B., Schulz, O., Hardtke-Wolenski, M., Schippers, A., Wagner, N., Müller, W., Sparwasser, T., Förster, R., Pabst, O., Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 34 (2011), 237–246.
48. Hallen-Adams, H.E., Suhr, M.J., Fungi in the healthy human gastrointestinal tract. Virulence 8 (2017), 352–358.
49. Harrison, O.J., Linehan, J.L., Shih, H.Y., Bouladoux, N., Han, S.J., Smelkinson, M., Sen, S.K., Byrd, A.L., Enamorado, M., Yao, C., et al. Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury. Science, 363, 2019, eaat6280.
50. Hoarau, G., Mukherjee, P.K., Gower-Rousseau, C., Hager, C., Chandra, J., Retuerto, M.A., Neut, C., Vermeire, S., Clemente, J., Colombel, J.F., et al. Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn's disease. MBio, 7, 2016 e01250–e01216.
51. Hoffmann, C., Dollive, S., Grunberg, S., Chen, J., Li, H., Wu, G.D., Lewis, J.D., Bushman, F.D., Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE, 8, 2013, e66019.
52. Huffnagle, G.B., Noverr, M.C., The emerging world of the fungal microbiome. Trends Microbiol. 21 (2013), 334–341.
53. Iliev, I.D., Dectin-1 exerts dual control in the gut. Cell Host Microbe 18 (2015), 139–141.
54. Iliev, I.D., Leonardi, I., Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat. Rev. Immunol. 17 (2017), 635–646.
55. Iliev, I.D., Spadoni, I., Mileti, E., Matteoli, G., Sonzogni, A., Sampietro, G.M., Foschi, D., Caprioli, F., Viale, G., Rescigno, M., Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 58 (2009), 1481–1489.
56. Iliev, I.D., Funari, V.A., Taylor, K.D., Nguyen, Q., Reyes, C.N., Strom, S.P., Brown, J., Becker, C.A., Fleshner, P.R., Dubinsky, M., et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336 (2012), 1314–1317.
57. Israeli, E., Grotto, I., Gilburd, B., Balicer, R.D., Goldin, E., Wiik, A., Shoenfeld, Y., Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54 (2005), 1232–1236.
58. Iwanaga, N., Kolls, J.K., Updates on T helper type 17 immunity in respiratory disease. Immunology 156 (2019), 3–8.
59. Jawhara, S., Habib, K., Maggiotto, F., Pignede, G., Vandekerckove, P., Maes, E., Dubuquoy, L., Fontaine, T., Guerardel, Y., Poulain, D., Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions. PLoS ONE, 7, 2012, e40648.
60. Jiang, T.T., Shao, T.Y., Ang, W.X.G., Kinder, J.M., Turner, L.H., Pham, G., Whitt, J., Alenghat, T., Way, S.S., Commensal fungi recapitulate the protective benefits of intestinal bacteria. Cell Host Microbe 22 (2017), 809–816.e4.
61. H2 inflammation. Nature 482 (2012), 395–399.
62. Kalan, L., Loesche, M., Hodkinson, B.P., Heilmann, K., Ruthel, G., Gardner, S.E., Grice, E.A., Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing. MBio, 7, 2016 e01058-16.
63. Kernbauer, E., Ding, Y., Cadwell, K., An enteric virus can replace the beneficial function of commensal bacteria. Nature 516 (2014), 94–98.
64. 2. Cell Host Microbe 15 (2014), 95–102.
65. Kim, S.H., Clark, S.T., Surendra, A., Copeland, J.K., Wang, P.W., Ammar, R., Collins, C., Tullis, D.E., Nislow, C., Hwang, D.M., et al. Global analysis of the fungal microbiome in cystic fibrosis patients reveals loss of function of the transcriptional repressor Nrg1 as a mechanism of pathogen adaptation. PLoS Pathog., 11, 2015, e1005308.
66. + intestinal mononuclear phagocyte regulation of intestinal T cell responses. Immunity 49 (2018), 151–163.e5.
67. Kiss, E.A., Vonarbourg, C., Kopfmann, S., Hobeika, E., Finke, D., Esser, C., Diefenbach, A., Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334 (2011), 1561–1565.
68. Knutsen, A.P., Bush, R.K., Demain, J.G., Denning, D.W., Dixit, A., Fairs, A., Greenberger, P.A., Kariuki, B., Kita, H., Kurup, V.P., et al. Fungi and allergic lower respiratory tract diseases. J. Allergy Clin. Immunol. 129 (2012), 280–291, quiz 292–293.
69. Krohn, S., Zeller, K., Böhm, S., Chatzinotas, A., Harms, H., Hartmann, J., Heidtmann, A., Herber, A., Kaiser, T., Treuheit, M., et al. Molecular quantification and differentiation of Candida species in biological specimens of patients with liver cirrhosis. PLoS ONE, 13, 2018, e0197319.
70. Lamas, B., Richard, M.L., Leducq, V., Pham, H.P., Michel, M.L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T.W., Natividad, J.M., et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22 (2016), 598–605.
71. Landsman, L., Bar-On, L., Zernecke, A., Kim, K.W., Krauthgamer, R., Shagdarsuren, E., Lira, S.A., Weissman, I.L., Weber, C., Jung, S., CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113 (2009), 963–972.
72. Lathrop, S.K., Bloom, S.M., Rao, S.M., Nutsch, K., Lio, C.W., Santacruz, N., Peterson, D.A., Stappenbeck, T.S., Hsieh, C.S., Peripheral education of the immune system by colonic commensal microbiota. Nature 478 (2011), 250–254.
73. Lemoinne, S., Kemgang, A., Ben Belkacem, K., Straube, M., Jegou, S., Corpechot, C., Chazouillères, O., Housset, C., Sokol, H., Saint-Antoine IBD Network. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut, 2019 gutjnl-2018-317791.
74. + mononuclear phagocytes control immunity to intestinal fungi. Science 359 (2018), 232–236.
75. Lewis, J.D., Abreu, M.T., Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology 152 (2017), 398–414.e6.
76. Lewis, J.D., Chen, E.Z., Baldassano, R.N., Otley, A.R., Griffiths, A.M., Lee, D., Bittinger, K., Bailey, A., Friedman, E.S., Hoffmann, C., et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe 18 (2015), 489–500.
77. Li, Q., Wang, C., Tang, C., He, Q., Li, N., Li, J., Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. J. Clin. Gastroenterol. 48 (2014), 513–523.
78. Li, X., Leonardi, I., Semon, A., Doron, I., Gao, I.H., Putzel, G.G., Kim, Y., Kabata, H., Artis, D., Fiers, W.D., et al. Response to fungal dysbiosis by gut-resident CX3CR1(+) mononuclear phagocytes aggravates allergic airway disease. Cell Host Microbe 24 (2018), 847–856.e4.
79. Liang, S.H., Anderson, M.Z., Hirakawa, M.P., Wang, J.M., Frazer, C., Alaalm, L.M., Thomson, G.J., Ene, I.V., Bennett, R.J., Hemizygosity enables a mutational transition governing fungal virulence and commensalism. Cell Host Microbe 25 (2019), 418–431.e6.
80. Liguori, G., Lamas, B., Richard, M.L., Brandi, G., da Costa, G., Hoffmann, T.W., Di Simone, M.P., Calabrese, C., Poggioli, G., Langella, P., et al. Fungal dysbiosis in mucosa-associated microbiota of Crohn's disease patients. J. Crohn's Colitis 10 (2016), 296–305.
81. Limon, J.J., Skalski, J.H., Underhill, D.M., Commensal fungi in health and disease. Cell Host Microbe 22 (2017), 156–165.
82. Limon, J.J., Tang, J., Li, D., Wolf, A.J., Michelsen, K.S., Funari, V., Gargus, M., Nguyen, C., Sharma, P., Maymi, V.I., et al. Malassezia is associated with Crohn's disease and exacerbates colitis in mouse models. Cell Host Microbe 25 (2019), 377–388.e6.
83. 3CR1-dependent renal macrophage survival promotes Candida control and host survival. J. Clin. Invest. 123 (2013), 5035–5051.
84. Lionakis, M.S., Iliev, I.D., Hohl, T.M., Immunity against fungi. JCI Insight, 2, 2017, 93156.
85. Lionakis, M.S., Levitz, S.M., Host control of fungal infections: lessons from basic studies and human cohorts. Annu. Rev. Immunol. 36 (2018), 157–191.
86. Mar, J.S., LaMere, B.J., Lin, D.L., Levan, S., Nazareth, M., Mahadevan, U., Lynch, S.V., Disease severity and immune activity relate to distinct interkingdom gut microbiome states in ethnically distinct ulcerative colitis patients. MBio, 7, 2016 e01072-16.
87. Marakalala, M.J., Vautier, S., Potrykus, J., Walker, L.A., Shepardson, K.M., Hopke, A., Mora-Montes, H.M., Kerrigan, A., Netea, M.G., Murray, G.I., et al. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS Pathog., 9, 2013, e1003315.
88. Maraki, S., Hajiioannou, I., Anatoliotakis, N., Plataki, M., Chatzinikolaou, I., Zoras, O., Tselentis, Y., Samonis, G., Ceftriaxone and dexamethasone affecting yeast gut flora in experimental mice. J. Chemother. 11 (1999), 363–366.
89. Martínez-López, M., Iborra, S., Conde-Garrosa, R., Mastrangelo, A., Danne, C., Mann, E.R., Reid, D.M., Gaboriau-Routhiau, V., Chaparro, M., Lorenzo, M.P., et al. Microbiota sensing by Mincle-Syk axis in dendritic cells regulates interleukin-17 and -22 production and promotes intestinal barrier integrity. Immunity 50 (2019), 446–461.e9.
90. Mason, K.L., Erb Downward, J.R., Mason, K.D., Falkowski, N.R., Eaton, K.A., Kao, J.Y., Young, V.B., Huffnagle, G.B., Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect. Immun. 80 (2012), 3371–3380.
91. + dendritic cells. Immunity 40 (2014), 248–261.
92. McAleer, J.P., Nguyen, N.L.H., Chen, K., Kumar, P., Ricks, D.M., Binnie, M., Armentrout, R.A., Pociask, D.A., Hein, A., Yu, A., et al. Pulmonary Th17 antifungal immunity is regulated by the gut microbiome. J. Immunol. 197 (2016), 97–107.
93. McGeachy, M.J., Cua, D.J., Gaffen, S.L., The IL-17 family of cytokines in health and disease. Immunity 50 (2019), 892–906.
94. Medina-Contreras, O., Geem, D., Laur, O., Williams, I.R., Lira, S.A., Nusrat, A., Parkos, C.A., Denning, T.L., CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J. Clin. Invest. 121 (2011), 4787–4795.
95. + cells by bacterial metabolites. Nature 566 (2019), 110–114.
96. Moyes, D.L., Wilson, D., Richardson, J.P., Mogavero, S., Tang, S.X., Wernecke, J., Höfs, S., Gratacap, R.L., Robbins, J., Runglall, M., et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 532 (2016), 64–68.
97. Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., Cheroutre, H., Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 (2007), 256–260.
98. Mukherjee, P.K., Sendid, B., Hoarau, G., Colombel, J.F., Poulain, D., Ghannoum, M.A., Mycobiota in gastrointestinal diseases. Nat. Rev. Gastroenterol. Hepatol. 12 (2015), 77–87.
99. Muratori, P., Muratori, L., Guidi, M., Maccariello, S., Pappas, G., Ferrari, R., Gionchetti, P., Campieri, M., Bianchi, F.B., Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin. Exp. Immunol. 132 (2003), 473–476.
100. Muthig, M., Hebestreit, A., Ziegler, U., Seidler, M., Müller, F.M., Persistence of Candida species in the respiratory tract of cystic fibrosis patients. Med. Mycol. 48 (2010), 56–63.
101. Naglik, J.R., König, A., Hube, B., Gaffen, S.L., Candida albicans-epithelial interactions and induction of mucosal innate immunity. Curr. Opin. Microbiol. 40 (2017), 104–112.
102. Nash, A.K., Auchtung, T.A., Wong, M.C., Smith, D.P., Gesell, J.R., Ross, M.C., Stewart, C.J., Metcalf, G.A., Muzny, D.M., Gibbs, R.A., et al. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome, 5, 2017, 153.
103. Nguyen, L.N., Lopes, L.C., Cordero, R.J., Nosanchuk, J.D., Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages. J. Antimicrob. Chemother. 66 (2011), 2573–2580.
104. Niess, J.H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B.A., Vyas, J.M., Boes, M., Ploegh, H.L., Fox, J.G., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005), 254–258.
105. Noverr, M.C., Noggle, R.M., Toews, G.B., Huffnagle, G.B., Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 72 (2004), 4996–5003.
106. Oh, J., Byrd, A.L., Park, M., Kong, H.H., Segre, J.A., NISC Comparative Sequencing Program. Temporal stability of the human skin microbiome. Cell 165 (2016), 854–866.
107. Ott, S.J., Kühbacher, T., Musfeldt, M., Rosenstiel, P., Hellmig, S., Rehman, A., Drews, O., Weichert, W., Timmis, K.N., Schreiber, S., Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand. J. Gastroenterol. 43 (2008), 831–841.
108. Pandiyan, P., Conti, H.R., Zheng, L., Peterson, A.C., Mathern, D.R., Hernández-Santos, N., Edgerton, M., Gaffen, S.L., Lenardo, M.J., CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34 (2011), 422–434.
109. Panea, C., Farkas, A.M., Goto, Y., Abdollahi-Roodsaz, S., Lee, C., Koscsó, B., Gowda, K., Hohl, T.M., Bogunovic, M., Ivanov, I.I., Intestinal monocyte-derived macrophages control commensal-specific Th17 responses. Cell Rep. 12 (2015), 1314–1324.
110. Panpetch, W., Somboonna, N., Palasuk, M., Hiengrach, P., Finkelman, M., Tumwasorn, S., Leelahavanichkul, A., Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium. PLoS ONE, 14, 2019, e0210798.
111. Papp, M., Norman, G.L., Vitalis, Z., Tornai, I., Altorjay, I., Foldi, I., Udvardy, M., Shums, Z., Dinya, T., Orosz, P., et al. Presence of anti-microbial antibodies in liver cirrhosis&a tell-tale sign of compromised immunity?. PLoS ONE, 5, 2010, e12957.
112. Paramsothy, S., Kamm, M.A., Kaakoush, N.O., Walsh, A.J., van den Bogaerde, J., Samuel, D., Leong, R.W.L., Connor, S., Ng, W., Paramsothy, R., et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389 (2017), 1218–1228.
113. Paramsothy, S., Nielsen, S., Kamm, M.A., Deshpande, N.P., Faith, J.J., Clemente, J.C., Paramsothy, R., Walsh, A.J., van den Bogaerde, J., Samuel, D., et al. Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis. Gastroenterology 156 (2019), 1440–1454.e2.
114. hi macrophages contributing to unilateral ureteral obstruction-induced fibrosis. J. Immunol. 195 (2015), 2797–2805.
115. Peterson, L.W., Artis, D., Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14 (2014), 141–153.
116. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., et al., MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
117. Qiu, X., Zhang, F., Yang, X., Wu, N., Jiang, W., Li, X., Li, X., Liu, Y., Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis. Sci. Rep., 5, 2015, 10416.
118. Raponi, G., Visconti, V., Brunetti, G., Ghezzi, M.C., Clostridium difficile infection and Candida colonization of the gut: is there a correlation?. Clin. Infect. Dis. 59 (2014), 1648–1649.
119. Richard, M.L., Sokol, H., The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases. Nat. Rev. Gastroenterol. Hepatol., 2019, 10.1038/s41575-019-0121-2.
120. Richardson, J.P., Ho, J., Naglik, J.R., Candida-Epithelial Interactions. J Fungi (Basel), 4, 2018, E22.
121. Richardson, J.P., Willems, H.M.E., Moyes, D.L., Shoaie, S., Barker, K.S., Tan, S.L., Palmer, G.E., Hube, B., Naglik, J.R., Peters, B.M., Candidalysin drives epithelial signaling, neutrophil recruitment, and immunopathology at the vaginal mucosa. Infect. Immun., 86, 2018 e00645-17.
122. Rizzetto, L., Ifrim, D.C., Moretti, S., Tocci, N., Cheng, S.C., Quintin, J., Renga, G., Oikonomou, V., De Filippo, C., Weil, T., et al. Fungal chitin induces trained immunity in human monocytes during cross-talk of the host with Saccharomyces cerevisiae. J. Biol. Chem. 291 (2016), 7961–7972.
123. Román, E., Huertas, B., Prieto, D., Díez-Orejas, R., Pla, J., TUP1-mediated filamentation in Candida albicans leads to inability to colonize the mouse gut. Future Microbiol. 13 (2018), 857–867.
124. Rooks, M.G., Garrett, W.S., Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16 (2016), 341–352.
125. Saeed, S., Quintin, J., Kerstens, H.H., Rao, N.A., Aghajanirefah, A., Matarese, F., Cheng, S.C., Ratter, J., Berentsen, K., van der Ent, M.A., et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science, 345, 2014, 1251086.
126. Salazar, F., Brown, G.D., Antifungal innate immunity: a perspective from the last 10 years. J. Innate Immun. 10 (2018), 373–397.
127. Samonis, G., Gikas, A., Anaissie, E.J., Vrenzos, G., Maraki, S., Tselentis, Y., Bodey, G.P., Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob. Agents Chemother. 37 (1993), 51–53.
128. Schaffer, T., Müller, S., Flogerzi, B., Seibold-Schmid, B., Schoepfer, A.M., Seibold, F., Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflamm. Bowel Dis. 13 (2007), 1339–1346.
129. Sendid, B., Jawhara, S., Sarter, H., Maboudou, P., Thierny, C., Gower-Rousseau, C., Colombel, J.F., Poulain, D., Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S. cerevisiae in this setting. Virulence 9 (2018), 1224–1229.
130. Shao, T.Y., Ang, W.X.G., Jiang, T.T., Huang, F.S., Andersen, H., Kinder, J.M., Pham, G., Burg, A.R., Ruff, B., Gonzalez, T., et al. Commensal Candida albicans positively calibrates systemic Th17 immunological responses. Cell Host Microbe 25 (2019), 404–417.e6.
131. Skalski, J.H., Limon, J.J., Sharma, P., Gargus, M.D., Nguyen, C., Tang, J., Coelho, A.L., Hogaboam, C.M., Crother, T.R., Underhill, D.M., Expansion of commensal fungus Wallemia mellicola in the gastrointestinal mycobiota enhances the severity of allergic airway disease in mice. PLoS Pathog., 14, 2018, e1007260.
132. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly-Y, M., Glickman, J.N., Garrett, W.S., The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573.
133. Sokol, H., Leducq, V., Aschard, H., Pham, H.P., Jegou, S., Landman, C., Cohen, D., Liguori, G., Bourrier, A., Nion-Larmurier, I., et al. Fungal microbiota dysbiosis in IBD. Gut 66 (2017), 1039–1048.
134. Sovran, B., Planchais, J., Jegou, S., Straube, M., Lamas, B., Natividad, J.M., Agus, A., Dupraz, L., Glodt, J., Da Costa, G., et al. Enterobacteriaceae are essential for the modulation of colitis severity by fungi. Microbiome, 6, 2018, 152.
135. Sparber, F., De Gregorio, C., Steckholzer, S., Ferreira, F.M., Dolowschiak, T., Ruchti, F., Kirchner, F.R., Mertens, S., Prinz, I., Joller, N., et al. The skin commensal yeast Malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation. Cell Host Microbe 25 (2019), 389–403.e6.
136. Standaert-Vitse, A., Jouault, T., Vandewalle, P., Mille, C., Seddik, M., Sendid, B., Mallet, J.M., Colombel, J.F., Poulain, D., Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 130 (2006), 1764–1775.
137. Standaert-Vitse, A., Sendid, B., Joossens, M., François, N., Vandewalle-El Khoury, P., Branche, J., Van Kruiningen, H., Jouault, T., Rutgeerts, P., Gower-Rousseau, C., et al. Candida albicans colonization and ASCA in familial Crohn's disease. Am. J. Gastroenterol. 104 (2009), 1745–1753.
138. Sudfeld, C.R., Dasenbrook, E.C., Merz, W.G., Carroll, K.C., Boyle, M.P., Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis. J. Cyst. Fibros. 9 (2010), 110–116.
139. Suez, J., Zmora, N., Zilberman-Schapira, G., Mor, U., Dori-Bachash, M., Bashiardes, S., Zur, M., Regev-Lehavi, D., Ben-Zeev Brik, R., Federici, S., et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell 174 (2018), 1406–1423.e16.
140. Suhr, M.J., Banjara, N., Hallen-Adams, H.E., Sequence-based methods for detecting and evaluating the human gut mycobiome. Lett. Appl. Microbiol. 62 (2016), 209–215.
141. Sun, C.M., Hall, J.A., Blank, R.B., Bouladoux, N., Oukka, M., Mora, J.R., Belkaid, Y., Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204 (2007), 1775–1785.
142. Tang, C., Kamiya, T., Liu, Y., Kadoki, M., Kakuta, S., Oshima, K., Hattori, M., Takeshita, K., Kanai, T., Saijo, S., et al. Inhibition of dectin-1 signaling ameliorates colitis by inducing Lactobacillus-mediated regulatory T cell expansion in the intestine. Cell Host Microbe 18 (2015), 183–197.
143. Tipton, L., Müller, C.L., Kurtz, Z.D., Huang, L., Kleerup, E., Morris, A., Bonneau, R., Ghedin, E., Fungi stabilize connectivity in the lung and skin microbial ecosystems. Microbiome, 6, 2018, 12.
144. Tso, G.H.W., Reales-Calderon, J.A., Tan, A.S.M., Sem, X., Le, G.T.T., Tan, T.G., Lai, G.C., Srinivasan, K.G., Yurieva, M., Liao, W., et al. Experimental evolution of a fungal pathogen into a gut symbiont. Science 362 (2018), 589–595.
145. van Leeuwen, P.T., van der Peet, J.M., Bikker, F.J., Hoogenkamp, M.A., Oliveira Paiva, A.M., Kostidis, S., Mayboroda, O.A., Smits, W.K., Krom, B.P., Interspecies Interactions between Clostridium difficile and Candida albicans. MSphere, 1, 2016 e00187-16.
146. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., de Vos, W.M., Visser, C.E., Kuijper, E.J., Bartelsman, J.F., Tijssen, J.G., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368 (2013), 407–415.
147. Vargas, S.L., Patrick, C.C., Ayers, G.D., Hughes, W.T., Modulating effect of dietary carbohydrate supplementation on Candida albicans colonization and invasion in a neutropenic mouse model. Infect. Immun. 61 (1993), 619–626.
148. Verma, A.H., Richardson, J.P., Zhou, C., Coleman, B.M., Moyes, D.L., Ho, J., Huppler, A.R., Ramani, K., McGeachy, M.J., Mufazalov, I.A., et al. Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. Sci. Immunol., 2, 2017, eaam8834.
149. H17-dependent inflammation. Sci. Transl. Med., 9, 2017, eaaf9655.
150. Wang, T., Pan, D., Zhou, Z., You, Y., Jiang, C., Zhao, X., Lin, X., Dectin-3 deficiency promotes colitis development due to impaired antifungal innate immune responses in the gut. PLoS Pathog., 12, 2016, e1005662.
151. Wang, Y., Wiesnoski, D.H., Helmink, B.A., Gopalakrishnan, V., Choi, K., DuPont, H.L., Jiang, Z.D., Abu-Sbeih, H., Sanchez, C.A., Chang, C.C., et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat. Med. 24 (2018), 1804–1808.
152. Wheeler, M.L., Limon, J.J., Bar, A.S., Leal, C.A., Gargus, M., Tang, J., Brown, J., Funari, V.A., Wang, H.L., Crother, T.R., et al. Immunological consequences of intestinal fungal dysbiosis. Cell Host Microbe 19 (2016), 865–873.
153. Whibley, N., Maccallum, D.M., Vickers, M.A., Zafreen, S., Waldmann, H., Hori, S., Gaffen, S.L., Gow, N.A., Barker, R.N., Hall, A.M., Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge. Eur. J. Immunol. 44 (2014), 1069–1083.
154. Witchley, J.N., Penumetcha, P., Abon, N.V., Woolford, C.A., Mitchell, A.P., Noble, S.M., Candida albicans morphogenesis programs control the balance between gut commensalism and invasive infection. Cell Host Microbe 25 (2019), 432–443.e6.
155. Yang, A.M., Inamine, T., Hochrath, K., Chen, P., Wang, L., Llorente, C., Bluemel, S., Hartmann, P., Xu, J., Koyama, Y., et al. Intestinal fungi contribute to development of alcoholic liver disease. J. Clin. Invest. 127 (2017), 2829–2841.
156. Zelante, T., Iannitti, R.G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D'Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2013), 372–385.
157. Zmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., Kotler, E., Zur, M., Regev-Lehavi, D., Brik, R.B., et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174 (2018), 1388–1405.e21.
158. Zuo, T., Wong, S.H., Cheung, C.P., Lam, K., Lui, R., Cheung, K., Zhang, F., Tang, W., Ching, J.Y.L., Wu, J.C.Y., et al. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection. Nat. Commun., 9, 2018, 3663.